Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.

Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen RC, Sadovsky R, Seftel AD, Vlachopoulos C, Wu FC.

J Urol. 2013 Jun;189(6):2031-8. doi: 10.1016/j.juro.2012.12.107. Epub 2013 Jan 9. Review.

PMID:
23313195
2.

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R.

Am J Cardiol. 2005 Jul 15;96(2):313-21. Review.

PMID:
16018863
3.

Erectile dysfunction in the cardiovascular patient.

Vlachopoulos C, Jackson G, Stefanadis C, Montorsi P.

Eur Heart J. 2013 Jul;34(27):2034-46. doi: 10.1093/eurheartj/eht112. Epub 2013 Apr 24. Review.

PMID:
23616415
4.

A systematic review of the association between erectile dysfunction and cardiovascular disease.

Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, Vlachopoulos C.

Eur Urol. 2014 May;65(5):968-78. doi: 10.1016/j.eururo.2013.08.023. Epub 2013 Aug 23. Review.

PMID:
24011423
5.

Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population?

Lee JC, Bénard F, Carrier S, Talwar V, Defoy I.

BJU Int. 2011 Mar;107(6):956-60. doi: 10.1111/j.1464-410X.2010.09691.x. Epub 2010 Oct 15.

6.

Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men.

Heruti RJ, Steinvil A, Shochat T, Saar N, Mashav N, Arbel Y, Justo D.

Isr Med Assoc J. 2008 Oct;10(10):686-90.

7.

Pharmacotherapeutic management of erectile dysfunction.

Hawksworth DJ, Burnett AL.

Clin Pharmacol Ther. 2015 Dec;98(6):602-10. doi: 10.1002/cpt.261. Epub 2015 Oct 30. Review.

PMID:
26352006
8.

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R.

Am J Cardiol. 2005 Dec 26;96(12B):85M-93M. Epub 2005 Dec 27.

PMID:
16387575
9.

The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males.

Francis ME, Kusek JW, Nyberg LM, Eggers PW.

J Urol. 2007 Aug;178(2):591-6; discussion 596. Epub 2007 Jun 13.

PMID:
17570434
11.

Men's health in primary care: an emerging paradigm of sexual function and cardiometabolic risk.

Miner MM.

Urol Clin North Am. 2012 Feb;39(1):1-23. doi: 10.1016/j.ucl.2011.09.003. Review.

PMID:
22118341
12.

Diabetic autonomic neuropathy.

Vinik AI, Maser RE, Mitchell BD, Freeman R.

Diabetes Care. 2003 May;26(5):1553-79. Review.

PMID:
12716821
13.

Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel.

Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R.

J Sex Med. 2005 Jan;2(1):40-50; discussion 50-2.

PMID:
16422903
14.

Cardiovascular risk factors determine erectile and arterial function response to sildenafil.

Solomon H, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Jackson G.

Am J Hypertens. 2006 Sep;19(9):915-9.

PMID:
16942933
15.

The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.

Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL.

Arch Intern Med. 2011 Nov 14;171(20):1797-803. doi: 10.1001/archinternmed.2011.440. Epub 2011 Sep 12.

PMID:
21911624
16.

Erectile dysfunction and its association with metabolic syndrome and endothelial function among patients with type 2 diabetes mellitus.

Ryan JG, Gajraj J.

J Diabetes Complications. 2012 Mar-Apr;26(2):141-7. doi: 10.1016/j.jdiacomp.2011.12.001. Epub 2012 Mar 20. Review.

PMID:
22437118
17.

[The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].

Bryniarski L, Rzepecki M, Klocek M, Wyczołkowski M.

Przegl Lek. 2009;66(4):192-7. Review. Polish.

PMID:
19708509
18.

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I.

Arch Intern Med. 2006 Jan 23;166(2):213-9.

PMID:
16432091
19.

The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.

Jackson G, Rosen RC, Kloner RA, Kostis JB.

J Sex Med. 2006 Jan;3(1):28-36; discussion 36. Review.

PMID:
16409215
20.

[Cardiovascular diseases and erectile dysfunction].

Pomeshkina SA, Pomeshkin EV, Barbarash OL, Neĭmark AI.

Ter Arkh. 2010;82(10):37-40. Russian.

PMID:
21341462

Supplemental Content

Support Center